GoKawiilUniversity of Kentucky study restores mice sleep by targeting immune cells, not plaques
Researchers at the University of Kentucky found that temporarily depleting microglia, the brain's resident immune cells, restored more than two hours of sleep per day in mice with Alzheimer's-like brain changes, without removing amyloid plaques. The team, led by Shannon L. Macauley and first author Nicholas J. Constantino, published the findings in Alzheimer's & Dementia, showing mice also spent more time in deep, restorative sleep stages.
GoKawiil's interpretation of the reporting above, not reported fact.
The result challenges the assumption that amyloid plaques themselves are the direct cause of Alzheimer's-related sleep disruption, pointing instead to inflammatory immune activity as a separate, potentially treatable driver. Macauley calls the finding 'paradigm-shifting,' suggesting that future therapies could target microglial inflammation to improve sleep without needing to clear plaques. Because the work is in mice, it remains uncertain whether similar immune-targeted approaches would be safe or effective in human patients.
- Depleting microglia restored over two hours of daily sleep in Alzheimer's model mice
- Sleep improved without reduction in amyloid plaque levels
- Findings suggest brain inflammation, not just plaques, disrupts sleep in Alzheimer's
Source: sciencedaily.com, 2026-10-24
Published there as: “Alzheimer's breakthrough: 2 hrs of sleep restored without clearing brain plaques”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.